http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104903294-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_96a099d7f133002a052b513e797e0190
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_806f0a3a49d26f0b2efb79a3ea184ce9
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4412
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
filingDate 2014-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3684f80e11f8552f80658a07e7ccc0da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9489592ed1f86960896dd8014400e4f3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd25eab6a53de5622ea4373d6790c3d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d8a193c28c1f243d3d54d9e5415e5e1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ecc4e7e651a45c13cf9483862a681a06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8e94c96fde8322a8b71486b05201fd1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27ddc084d2ecb5e81b53ec666e54e079
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5562bcb461aef2d9702e32384ca74c9
publicationDate 2015-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104903294-A
titleOfInvention Pyridone derivatives and their use in treating, improving or preventing viral diseases
abstract The present invention relates to a compound with general formula (II) that can be used to treat, improve or prevent viral diseases, which is optionally a pharmaceutically acceptable salt, solvate, polymorph, drug, co-crystal, prodrug, In the form of tautomers, racemates, enantiomers or diastereomers or mixtures thereof. Furthermore, specific combination therapies are disclosed.
priorityDate 2013-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012022255-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467064896
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467064897
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422063979
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86725718
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466379681
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86725705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413222479
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467522419

Total number of triples: 37.